ATYR FY 2022 Earnings — aTyr Pharma, Inc. Revenue & Financial Results | Market Cap Arena

ATYRaTyr Pharma, Inc.

$93M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M

Gross Profit

$9M83.7% margin

Operating Income

-$46M-446.8% margin

Net Income

-$45M-436.5% margin

EPS (Diluted)

$-1.60

Cash Flow

Operating Cash Flow

-$42M

Free Cash Flow

-$44M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$96M

Total Liabilities

$25M

Stockholders' Equity

$71M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$0	—
Gross Profit	$9M	-$1M	+766.5%
Operating Income	-$46M	-$34M	-36.4%
Net Income	-$45M	-$34M	-34.3%